BRIEF published on 11/14/2025 at 23:10, 20 days 9 hours ago MaaT Pharma: successful fundraising of 9.1 million euros Investors Biotechnology Fundraising Microbiome Medical Innovation
PRESS RELEASE published on 11/14/2025 at 23:05, 20 days 9 hours ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) MaaT Pharma annonce le succès de son Offre Globale de 9,1 millions d'euros pour le développement de Microbiome Ecosystem Therapies™. Levée de fonds pour Xervyteg® et MaaT033 Microbiome Ecosystem Therapies Offre Globale MaaT Pharma MaaT033 Xervyteg
PRESS RELEASE published on 11/14/2025 at 23:05, 20 days 9 hours ago Inside Information / Operations of the issuer (acquisitions, sales...) MaaT Pharma successfully completes Global Offering of €9.1 million, strengthening financial position and supporting development of Microbiome Therapies for cancer patients Financial Position Global Offering MaaT Pharma Cancer Patients Microbiome Therapies
BRIEF published on 11/13/2025 at 19:45, 21 days 12 hours ago Lancement d'une augmentation de capital par MaaT Pharma Augmentation De Capital Investisseurs Qualifiés Offre Globale MaaT Pharma Xervyteg® Commercialisation
BRIEF published on 11/13/2025 at 19:45, 21 days 12 hours ago MaaT Pharma launches a capital increase Capital Increase Qualified Investors MaaT Pharma Global Offer Xervyteg® Marketing
PRESS RELEASE published on 11/13/2025 at 19:40, 21 days 12 hours ago Inside Information / Other news releases MaaT Pharma launches a capital increase of approximately €9 million through a private placement and PrimaryBid offering. Funds raised to support Xervyteg® commercialization and extend cash runway until summer 2026 Private Placement Investment Capital Increase MaaT Pharma Xervyteg
PRESS RELEASE published on 11/13/2025 at 19:40, 21 days 12 hours ago Informations privilégiées / Autres communiqués MaaT Pharma lance une augmentation de capital de 9 millions d'euros pour financer son développement. Offre d'actions nouvelles aux investisseurs. Projets de développement clinique et commercialisation Développement Augmentation De Capital Commercialisation Actions Nouvelles MaaT Pharma
BRIEF published on 11/05/2025 at 07:35, 1 month ago MaaT Pharma Reveals Promising Preclinical Data for MaaT034 Cancer Treatment Immunotherapy MaaT Pharma Microbiome Therapy MaaT034
BRIEF published on 11/05/2025 at 07:35, 1 month ago MaaT Pharma dévoile des données précliniques prometteuses pour MaaT034 Immunothérapie Traitement Du Cancer MaaT Pharma Thérapie Du Microbiome MaaT034
PRESS RELEASE published on 11/05/2025 at 07:30, 1 month ago Inside Information / Other news releases MaaT Pharma presents updated preclinical data for MaaT034, showing immune activation and anti-tumor activity at SITC Annual Meeting. New findings enhance patient responses to immunotherapy Preclinical Data MaaT Pharma SITC Annual Meeting Immune Activation Anti-tumor Activity
Published on 12/05/2025 at 02:35, 5 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 08:05, 19 minutes ago Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 24 minutes ago Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 24 minutes ago Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 24 minutes ago Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 24 minutes ago Le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) croît et est sur le point de franchir la barre des 500 millions
Published on 12/04/2025 at 18:14, 14 hours 10 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 25 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 40 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
